EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vascular Disruption Therapy as a New Strategy for Cancer Treatment

Jesús Gómez-Escudero, Patricia Berlana-Galán iD, Elena Guerra-Paes iD, Irene Torre-Cea iD, Laura Marcos-Zazo iD, Iván Carrera-Aguado iD, Daniel Cáceres-Calle iD, Fernando Sánchez-Juanes iD, José M Muñoz-Félix

International Journal of Molecular Sciences · 16.10.2025 · 26 (20) · 10085

DOI: 10.3390/ijms262010085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.10.2025. Verfasst von Jesús Gómez-Escudero und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, 37007 Salamanca, Spain. Hauptthemen laut MEDLINE: Neoplasms, Neovascularization, Pathologic, Angiogenesis Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fundación Mutua Madrileña, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A functional blood vessel network is required to deliver oxygen and nutrients to the cancer cells for their growth. Angiogenesis, the formation of new blood vessels from pre-existing ones, is one of the major mechanisms to create this vascular network. Anti-angiogenic therapy was conceived as the inhibition of the cellular and molecular players involved in tumor angiogenesis such as vascular endothelial growth factor and its main receptors. Due to limitations of this therapy, different approaches of vessel modulation such as vascular normalization or vascular promotion have been studied showing benefits in different tumor models and clinical trials. In contrast to anti-angiogenic therapy, which inhibits the blood vessels that are being formed, vascular disruption therapy aims to destroy already formed tumor vessels. These malignant vascular structures differ from other blood vessels in terms of endothelial cell states, pericyte coverage and basement membrane development. The molecules used for vascular disruption are microtubule-binding molecules, flavonoids that induce endothelial cell apoptosis or molecules vectorized to endothelial receptors. Many vascular disruption agents have been tested in clinical trials showing some promising results, but with some limitations that include resistant rim cells or the development of hypoxia that induces cancer regrowth and poor delivery of the anti-tumor agents. The main objective of this review is to focus on vascular disruption agents therapy, novel molecules, new ways to overcome therapy resistance to them, current clinical status and, especially, the upcoming challenges and applications of these molecules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNeovascularization, PathologicAngiogenesis InhibitorsHumansAnimals

Stichwörter der Autor:innen

angiogenesistumor vasculaturevascular disruptionvascular disruption agents

Substanzen

Angiogenesis Inhibitors

Autor:innen und Institutionen

  • Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, 37007 Salamanca, Spain.
  • Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain.

ORCID-Profile: Patricia Berlana-Galán, Elena Guerra-Paes, Irene Torre-Cea, Laura Marcos-Zazo, Iván Carrera-Aguado, Daniel Cáceres-Calle, Fernando Sánchez-Juanes

Förderung

  • Instituto de Salud Carlos III
  • Fundación Mutua Madrileña
  • Ministerio de Ciencia, Innovación y Universidades
  • Fundación Científica de la Asociación Española Contra el Cáncer
  • Junta de Castilla y León
  • Asociación Española Contra el Cáncer
  • European Social Fund
  • Universidad de Salamanca and Banco Santander

Zitieren

APA

Gómez-Escudero, J., Berlana-Galán, P., Guerra-Paes, E., Torre-Cea, I., Marcos-Zazo, L., Carrera-Aguado, I., Cáceres-Calle, D., Sánchez-Juanes, F., & Muñoz-Félix, J. M. (2025). Vascular Disruption Therapy as a New Strategy for Cancer Treatment. International Journal of Molecular Sciences, 26(20), 10085. https://doi.org/10.3390/ijms262010085

Vancouver

Gómez-Escudero J, Berlana-Galán P, Guerra-Paes E, Torre-Cea I, Marcos-Zazo L, Carrera-Aguado I, et al. Vascular Disruption Therapy as a New Strategy for Cancer Treatment. International Journal of Molecular Sciences. 2025;26(20):10085. doi:10.3390/ijms262010085

BibTeX
@article{GmezEscudero2025,
  author = {Gómez-Escudero, Jesús and Berlana-Galán, Patricia and Guerra-Paes, Elena and Torre-Cea, Irene and Marcos-Zazo, Laura and Carrera-Aguado, Iván and Cáceres-Calle, Daniel and Sánchez-Juanes, Fernando and Muñoz-Félix, José M},
  title = {Vascular Disruption Therapy as a New Strategy for Cancer Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {10085},
  doi = {10.3390/ijms262010085}
}
Kostenlos starten →